EFFECT OF KK1 PEPTIDE ON MAINTENANCE OF APOPTOSIS MARKERS IN RATS BRAIN CAUSED BY SEVERE CARBON OXIDE POISONING

Carbon oxide poisoning leads to the development of delayed CNS functions disturbances. These disturbances may be not only linked to the development of hemic hypoxia. In a number of research works, nonspecific neurotoxic carbon oxide mechanisms of action were described, one of which is activation of programmed cell death developing as apoptosis. One of the preparations having neuroprotective action mode is a synthetic analog sequence of adrenokortikotropic hormone – KK1 peptide. In this research, laboratory animals were exposed to acute heavy carbon oxide poisoning in a dose of 0.8 LC50 within 30 min. KK1 peptide was administrated intranasally in a dose of 40 mkg/kg/day within 5 days. In rats brain gomogenates, the maintenance of active forms of marker proteins associated with apoptosis early stages was investigated at different time after intoxication with carbon oxide. As a result of the conducted research, it was established that the use of KK1 peptide leads to the decrease of the maintenance of r53 protein active forms and Akt1 protein kinase on 7th and 14th days after a heavy poisoning with carbon oxide. Results of the experiment performed allow to suggest that at that type of pathology the potential mechanism of neuroprotective effect of synthetic KK1 tetrapeptide is connected with restricted development of apoptosis in brain.

carbon oxide, neurotoxicity, apoptosis, Akt1 protein kinase, r53protein, KK1 peptide

1. Зобнин Ю. В. Отравление монооксидом углерода (угарным газом). СПб.: Тактик-Студио; 2011.

2. Braubach M., Algoet А., Beaton М. et al. Mortality associated with exposure to carbon monoxide in WHO European member states. Indoor Air. 2013; 23: 115-25.

3. Weawer L.K. Clinical practice. Carbon monoxide poisoning. N. Engl. J. Med. 2009; 360: 1217-25.

4. Oh S., Choi S. Acute carbon monoxide poisoning and delayed neurological sequelae: a potential neuroprotection bundle therapy. Neural Regen. Res. 2015: 10(1): 36-38.

5. Prockop L.D., Chichkova R.I. Carbon monoxide intoxication: an updated review. 2007: 262 (1-2): P. 122-30.

6. Тиунов Л. А. Токсикология окиси углерода. М.: Медицина: 1980.

7. Piantadosi C.A., Carraway M.S., Suliman H.B. Carbon monoxide, oxidative stress and mitochondrial permeability pore transition. Free Radic. Biol. Med. 2006; 40(8): 1332-39.

8. Thom R.S., Bhopale V.M., Hun S. et al. Intravascular neutrophil activation due to carbon monoxide poisoning. Am. J. Respir. Crit. Care Med. 2006: 174 (11): 1239-49.

9. Park E.J., Min Y., Kim G. et al. Pathophysiology of brain injuries in acute carbon monoxide poisoning: a novel hypothesis. Med. Hypotheses. 2014; 83: 186-89.

10. Piantadosi C.A., Zhang J., Levin E. et al. Apoptosis and delayed neuronal damage after carbon monoxide poisoning in the rat. Exp. Neurol. 1997; 147 (1): 103-14.

11. Вересов В. Г. Структурная биология апоптоза. Минск: Белорус. наука; 2008.

12. Claerhout S., Decraene D., Van Laethem A. et al. AKT delays the early-activated apoptotic pathway in UVB-irradiated keratinocytes via BAD translocationt, // J. Invest. Dermatol. 2007; 127 (2): 429-38.

13. Тетрапептид и средство, обладающее церебропротекторной и антиамнестической активностью (варианты) // Патент 2537560 С2 РФ. 2014 г.

14. Методические указания о количественном определении карбоксигемоглобина и карбоксимиоглобина. М.: МЗ СССР, 1974.

15. Шперлинг И. А. Патология эритроцита при экзогенных интоксикации. Томск: Издво Томского ун-та: 2006.

16. Tofiaghi R. Hypoxia-independed apoptosis in neural cells exposed to CO in vitro. Brain Resear. 2006; 1098: 1-8.

17. Li Q., Cheng Y., Bi M.G. et al. Effects of N-Butylphthalide on the expressions of Nogo/ NgR in rat brain tissue after carbon monoxide poisoning. Environ. Toxicol. Pharmacol. 2015; 39 (2); 953-61.

18. Черешнев В. А. Фармакологическое регулирование программированной гибели клеток. СПб.: Наука; 2011.

19. Deiko D.R., Shtrygol` S.Yu., Kolobov A.A. The mechanism of neuroprotective action of new oligopeptides-homologus of primary ACTH15-18 sequence. Topical issues of new drug development: abstracts of International Scientific and Practical Conference of Yong Scientist and Students (April 23 2015). – Kh.: Publishing office NUPh, 2015; 307-8.

20. Halterman M.W, Miller C.C., Federoff H.J. Hypoxia-inducible factor-1 alpha mediates hypoxia-induced delayed neuronal death that involves p53. J. Neurosci. 1999; 19: 6818-24.

21. Pore N, Jiang Z, Shu H.K. et al. Akt1 activation can augment hypoxiainducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway. Mol. Cancer Res. 2006 Jul; 4(7): 471-9.

22. Wegiel B., Chin B.Y., Otterbein L.E. Inhale to survive, cycle or die? Cell Cycle. 2008; 7: 1379-84.